Cell Harvesting Market Size, Share, Trends, Growth Outlook

Cell Harvesting Market is estimated to increase at a Compounded Annual Growth Rate of 9.3% CAGR over the forecast period from 2024 to 2030

The Cell Harvesting Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Type (Manual, Automated), By Application (Biopharmaceutical Application, Stem Cell Research, Others), By End-User (Biotechnology Companies, Biopharmaceutical Companies, Research Institutes, Others).

An Introduction to Cell Harvesting Market in 2024

Cell harvesting is the process of collecting cells from culture vessels or tissues for downstream analysis, manipulation, or therapeutic applications, such as cell-based assays, transplantation, or tissue engineering. In 2024, cell harvesting techniques include enzymatic dissociation, mechanical dissociation, and filtration methods, each designed to efficiently recover viable cells while minimizing cell damage or contamination. Enzymatic cell harvesting involves treating adherent cells with proteolytic enzymes to detach them from the culture substrate, while mechanical methods utilize scraping, scraping, or shaking to dislodge cells from tissue or culture vessels. Filtration techniques involve passing cell suspensions through porous membranes to separate cells from debris or aggregates. Cell harvesting is a critical step in cell-based research and bioprocessing, ensuring the isolation of high-quality cells for downstream applications. With advancements in harvesting protocols, automation, and sterile handling techniques, cell harvesting methods offer improved efficiency, yield, and reproducibility, supporting a wide range of biomedical applications, from basic research to clinical translation. As the demand for cell-based therapies and regenerative medicine continues to grow, cell harvesting remains a key enabling technology for harnessing the therapeutic potential of cells for treating diseases and restoring tissue function.

Market Trend: Adoption of Non-Invasive Cell Harvesting Techniques

A significant trend in the cell harvesting market is the increasing adoption of non-invasive harvesting techniques. Traditional methods often involve invasive procedures, such as tissue biopsies or enzymatic digestion, which can lead to tissue damage, cell stress, and contamination risks. In response to the need for gentler and more efficient cell harvesting methods, there's a growing interest in non-invasive alternatives. These techniques utilize principles such as magnetic separation, microfluidics, or mechanical agitation to isolate target cells from their natural environment while preserving their viability, functionality, and phenotype. The adoption of non-invasive cell harvesting techniques reflects a broader trend toward minimizing cell manipulation-induced stress and improving the quality of harvested cells for various applications, including regenerative medicine, cell therapy, and research.

Market Driver: Advancements in Cell-Based Therapies and Tissue Engineering

A key driver fueling the cell harvesting market is the advancements in cell-based therapies and tissue engineering. Cell-based therapies hold immense promise for treating a wide range of diseases and injuries, including cancer, cardiovascular disorders, and neurological conditions. The successful isolation and harvesting of therapeutic cells are essential steps in the development and manufacturing of cell-based therapies. Additionally, tissue engineering approaches require precise and efficient methods for harvesting cells from culture systems to fabricate functional tissues and organs for transplantation or in vitro modeling. As the field of regenerative medicine continues to advance and more cell-based therapies enter clinical practice, the demand for reliable and effective cell harvesting solutions continues to grow, driving market expansion.

Market Opportunity: Development of Automated and Scalable Harvesting Platforms

An opportunity within the cell harvesting market lies in the development of automated and scalable harvesting platforms. Traditional harvesting methods often involve manual handling, open manipulation, and batch processing, which can introduce contamination risks, variability, and labor-intensive workflows. Developing automated and scalable harvesting platforms offers several advantages, including enhanced sterility, reproducibility, and productivity. These platforms can integrate with upstream and downstream processes in cell therapy manufacturing workflows, facilitating seamless cell isolation, purification, and downstream processing. Companies investing in the development of automated and scalable harvesting platforms stand to address the evolving needs of cell therapy manufacturers, contract research organizations, and academic institutions, thereby capturing a significant Opportunity in cell harvesting technologies.

Cell Harvesting Market Share Analysis: Automated Cell Harvesting is the fastest growing segment over the forecast period to 2030

The automated cell harvesting segment is experiencing the fastest growth within the cell harvesting market, driven by several key factors. Firstly, automation offers significant advantages over manual harvesting methods in terms of efficiency, reproducibility, and scalability. Automated cell harvesting systems streamline the process, reducing labor requirements and minimizing variability in cell yield and quality, thus improving overall productivity. Secondly, as the demand for cell-based therapies, biopharmaceuticals, and regenerative medicine continues to rise, there is a growing need for efficient and reliable methods to isolate and collect target cells from culture systems. Automated harvesting systems offer precise control over harvesting parameters, such as timing and cell detachment methods, resulting in higher cell viability and purity, which are critical for downstream applications. Additionally, advancements in automation technologies, such as robotics and sensor integration, have led to the development of sophisticated harvesting platforms capable of handling various cell types and culture conditions with minimal user intervention. Moreover, the increasing adoption of cGMP-compliant manufacturing practices in biopharmaceutical and biotechnology industries further drives the demand for automated cell harvesting systems to ensure product consistency and compliance with regulatory standards. With ongoing innovations and expanding applications in cell therapy, tissue engineering, and bioprocessing, automated cell harvesting is poised to maintain its rapid growth trajectory in the cell harvesting market.

Cell Harvesting Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAlcami Corp, Arthrex Inc, AVITA Medical, Cox Scientific Ltd, Danaher Corp, Esco Lifesciences Group, Eurofins Scientific, Perkin Elmer Inc, Sartorius AG, Terumo Corp, Thermo Fisher Scientific Inc, Tomtec Inc

Cell Harvesting Market Segmentation

By Type
Manual
Automated
By Application
Biopharmaceutical Application
Stem Cell Research
Others
By End-User
Biotechnology Companies
Biopharmaceutical Companies
Research Institutes
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Cell Harvesting Market Companies

Alcami Corp
Arthrex Inc
AVITA Medical
Cox Scientific Ltd
Danaher Corp
Esco Lifesciences Group
Eurofins Scientific
Perkin Elmer Inc
Sartorius AG
Terumo Corp
Thermo Fisher Scientific Inc
Tomtec Inc

Reasons to Buy the Cell Harvesting Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Cell Harvesting Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Cell Harvesting Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Cell Harvesting Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Cell Harvesting Market Size Outlook, $ Million, 2021 to 2030
3.2 Cell Harvesting Market Outlook by Type, $ Million, 2021 to 2030
3.3 Cell Harvesting Market Outlook by Product, $ Million, 2021 to 2030
3.4 Cell Harvesting Market Outlook by Application, $ Million, 2021 to 2030
3.5 Cell Harvesting Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Cell Harvesting Industry
4.2 Key Market Trends in Cell Harvesting Industry
4.3 Potential Opportunities in Cell Harvesting Industry
4.4 Key Challenges in Cell Harvesting Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Cell Harvesting Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Cell Harvesting Market Outlook by Segments
7.1 Cell Harvesting Market Outlook by Segments, $ Million, 2021- 2030
By Type
Manual
Automated
By Application
Biopharmaceutical Application
Stem Cell Research
Others
By End-User
Biotechnology Companies
Biopharmaceutical Companies
Research Institutes
Others

8 North America Cell Harvesting Market Analysis and Outlook To 2030
8.1 Introduction to North America Cell Harvesting Markets in 2024
8.2 North America Cell Harvesting Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Cell Harvesting Market size Outlook by Segments, 2021-2030
By Type
Manual
Automated
By Application
Biopharmaceutical Application
Stem Cell Research
Others
By End-User
Biotechnology Companies
Biopharmaceutical Companies
Research Institutes
Others

9 Europe Cell Harvesting Market Analysis and Outlook To 2030
9.1 Introduction to Europe Cell Harvesting Markets in 2024
9.2 Europe Cell Harvesting Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Cell Harvesting Market Size Outlook by Segments, 2021-2030
By Type
Manual
Automated
By Application
Biopharmaceutical Application
Stem Cell Research
Others
By End-User
Biotechnology Companies
Biopharmaceutical Companies
Research Institutes
Others

10 Asia Pacific Cell Harvesting Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Cell Harvesting Markets in 2024
10.2 Asia Pacific Cell Harvesting Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Cell Harvesting Market size Outlook by Segments, 2021-2030
By Type
Manual
Automated
By Application
Biopharmaceutical Application
Stem Cell Research
Others
By End-User
Biotechnology Companies
Biopharmaceutical Companies
Research Institutes
Others

11 South America Cell Harvesting Market Analysis and Outlook To 2030
11.1 Introduction to South America Cell Harvesting Markets in 2024
11.2 South America Cell Harvesting Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Cell Harvesting Market size Outlook by Segments, 2021-2030
By Type
Manual
Automated
By Application
Biopharmaceutical Application
Stem Cell Research
Others
By End-User
Biotechnology Companies
Biopharmaceutical Companies
Research Institutes
Others
12 Middle East and Africa Cell Harvesting Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Cell Harvesting Markets in 2024
12.2 Middle East and Africa Cell Harvesting Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Cell Harvesting Market size Outlook by Segments, 2021-2030
By Type
Manual
Automated
By Application
Biopharmaceutical Application
Stem Cell Research
Others
By End-User
Biotechnology Companies
Biopharmaceutical Companies
Research Institutes
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Alcami Corp
Arthrex Inc
AVITA Medical
Cox Scientific Ltd
Danaher Corp
Esco Lifesciences Group
Eurofins Scientific
Perkin Elmer Inc
Sartorius AG
Terumo Corp
Thermo Fisher Scientific Inc
Tomtec Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Type
Manual
Automated
By Application
Biopharmaceutical Application
Stem Cell Research
Others
By End-User
Biotechnology Companies
Biopharmaceutical Companies
Research Institutes
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)